Elevated Level of Blood Lysosphingolipids in Patients with Schizophrenia
Schizophrenia is a mental disorder with a prevalence of 0.7–1% of the general population and is characterized by impaired dopamine transmission in neurons. Recent data have shown that lysosomal storage disorders (LSD), characterized by a decrease in enzyme activity and a corresponding accumulation o...
Gespeichert in:
| Veröffentlicht in: | Russian journal of genetics 2023-06, Vol.59 (6), p.579-584 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 584 |
|---|---|
| container_issue | 6 |
| container_start_page | 579 |
| container_title | Russian journal of genetics |
| container_volume | 59 |
| creator | Kopytova, A. E. Usenko, T. S. Bezrukova, A. I. Basharova, K. S. Andreeva, T. V. Volkova, E. V. Manakhov, A. D. Baydakova, G. V. Palchikova, E. I. Zakharova, E. Yu Zalutskaya, N. M. Neznanov, N. G. Pchelina, S. N. |
| description | Schizophrenia is a mental disorder with a prevalence of 0.7–1% of the general population and is characterized by impaired dopamine transmission in neurons. Recent data have shown that lysosomal storage disorders (LSD), characterized by a decrease in enzyme activity and a corresponding accumulation of substrate in lysosomes due to mutations in lysosomal genes, can manifest a wide range of clinical symptoms including psychosis, affective disorders, early onset dementia, and schizophrenia. The purpose of this study is to assess the level of lysosphingolipids in patients with schizophrenia, Parkinson’s disease (PD), and the control. The study includes 52 patients with schizophrenia, 170 patients with PD, and 166 neurologically healthy individuals (control group). The concentration of lysosomal substrates (hexosylsphingosine (HexSph), globotriaosylsphingosine (LysoGb3), lysosphingomyelin (LysoSM)) are measured by high-liquid chromatography with tandem mass spectrometry (HPLC-MS/MS) in blood. An increase in the concentration of LysoSM, LysoGb3, and HexSph is detected in patients with schizophrenia compared to the control (
p
< 0.0001,
p
< 0.0001,
p
< 0.0001, respectively). Our results confirm a violation of the lysosphingolipid composition of the blood in patients with schizophrenia. |
| doi_str_mv | 10.1134/S102279542306008X |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3153575295</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3153575295</sourcerecordid><originalsourceid>FETCH-LOGICAL-c321t-c77fd6b9cacc4682e9a92b8b846d9387493f26f817941ee28dfd52a0f7dfeb23</originalsourceid><addsrcrecordid>eNp9kM1OwzAQhC0EEqXwANxy5BLwT-LYR6gKRYoEUnvgFjnOunGV2sFOi8rTk6rckDjtruablWYQuiX4nhCWPSwJprSQeUYZ5hiLjzM0IRyLlDEuz8d9lNOjfomuYtxgTDDmbIIW8w72aoAmKWEPXeJN8tR5P56H6GPfWrf2ne1tExPrknc1WHBDTL7s0CZL3dpv37cBnFXX6MKoLsLN75yi1fN8NVuk5dvL6-yxTDWjZEh1UZiG11IrrTMuKEglaS1qkfFGMlFkkhnKjSCFzAgAFY1pcqqwKRoDNWVTdHd62wf_uYM4VFsbNXSdcuB3sWIkZ3mRU5mPKDmhOvgYA5iqD3arwqEiuDqWVv0pbfTQkyeOrFtDqDZ-F9wY6B_TD0h0bv8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3153575295</pqid></control><display><type>article</type><title>Elevated Level of Blood Lysosphingolipids in Patients with Schizophrenia</title><source>SpringerLink Journals</source><creator>Kopytova, A. E. ; Usenko, T. S. ; Bezrukova, A. I. ; Basharova, K. S. ; Andreeva, T. V. ; Volkova, E. V. ; Manakhov, A. D. ; Baydakova, G. V. ; Palchikova, E. I. ; Zakharova, E. Yu ; Zalutskaya, N. M. ; Neznanov, N. G. ; Pchelina, S. N.</creator><creatorcontrib>Kopytova, A. E. ; Usenko, T. S. ; Bezrukova, A. I. ; Basharova, K. S. ; Andreeva, T. V. ; Volkova, E. V. ; Manakhov, A. D. ; Baydakova, G. V. ; Palchikova, E. I. ; Zakharova, E. Yu ; Zalutskaya, N. M. ; Neznanov, N. G. ; Pchelina, S. N.</creatorcontrib><description>Schizophrenia is a mental disorder with a prevalence of 0.7–1% of the general population and is characterized by impaired dopamine transmission in neurons. Recent data have shown that lysosomal storage disorders (LSD), characterized by a decrease in enzyme activity and a corresponding accumulation of substrate in lysosomes due to mutations in lysosomal genes, can manifest a wide range of clinical symptoms including psychosis, affective disorders, early onset dementia, and schizophrenia. The purpose of this study is to assess the level of lysosphingolipids in patients with schizophrenia, Parkinson’s disease (PD), and the control. The study includes 52 patients with schizophrenia, 170 patients with PD, and 166 neurologically healthy individuals (control group). The concentration of lysosomal substrates (hexosylsphingosine (HexSph), globotriaosylsphingosine (LysoGb3), lysosphingomyelin (LysoSM)) are measured by high-liquid chromatography with tandem mass spectrometry (HPLC-MS/MS) in blood. An increase in the concentration of LysoSM, LysoGb3, and HexSph is detected in patients with schizophrenia compared to the control (
p
< 0.0001,
p
< 0.0001,
p
< 0.0001, respectively). Our results confirm a violation of the lysosphingolipid composition of the blood in patients with schizophrenia.</description><identifier>ISSN: 1022-7954</identifier><identifier>EISSN: 1608-3369</identifier><identifier>DOI: 10.1134/S102279542306008X</identifier><language>eng</language><publisher>Moscow: Pleiades Publishing</publisher><subject>Animal Genetics and Genomics ; Biomedical and Life Sciences ; Biomedicine ; blood ; chromatography ; dementia ; dopamine ; enzyme activity ; Human Genetics ; lysosomes ; Microbial Genetics and Genomics ; schizophrenia ; sphingolipids ; tandem mass spectrometry</subject><ispartof>Russian journal of genetics, 2023-06, Vol.59 (6), p.579-584</ispartof><rights>Pleiades Publishing, Inc. 2023. ISSN 1022-7954, Russian Journal of Genetics, 2023, Vol. 59, No. 6, pp. 579–584. © Pleiades Publishing, Inc., 2023. Russian Text © The Author(s), 2023, published in Genetika, 2023, Vol. 59, No. 6, pp. 670–675.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c321t-c77fd6b9cacc4682e9a92b8b846d9387493f26f817941ee28dfd52a0f7dfeb23</citedby><cites>FETCH-LOGICAL-c321t-c77fd6b9cacc4682e9a92b8b846d9387493f26f817941ee28dfd52a0f7dfeb23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1134/S102279542306008X$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1134/S102279542306008X$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Kopytova, A. E.</creatorcontrib><creatorcontrib>Usenko, T. S.</creatorcontrib><creatorcontrib>Bezrukova, A. I.</creatorcontrib><creatorcontrib>Basharova, K. S.</creatorcontrib><creatorcontrib>Andreeva, T. V.</creatorcontrib><creatorcontrib>Volkova, E. V.</creatorcontrib><creatorcontrib>Manakhov, A. D.</creatorcontrib><creatorcontrib>Baydakova, G. V.</creatorcontrib><creatorcontrib>Palchikova, E. I.</creatorcontrib><creatorcontrib>Zakharova, E. Yu</creatorcontrib><creatorcontrib>Zalutskaya, N. M.</creatorcontrib><creatorcontrib>Neznanov, N. G.</creatorcontrib><creatorcontrib>Pchelina, S. N.</creatorcontrib><title>Elevated Level of Blood Lysosphingolipids in Patients with Schizophrenia</title><title>Russian journal of genetics</title><addtitle>Russ J Genet</addtitle><description>Schizophrenia is a mental disorder with a prevalence of 0.7–1% of the general population and is characterized by impaired dopamine transmission in neurons. Recent data have shown that lysosomal storage disorders (LSD), characterized by a decrease in enzyme activity and a corresponding accumulation of substrate in lysosomes due to mutations in lysosomal genes, can manifest a wide range of clinical symptoms including psychosis, affective disorders, early onset dementia, and schizophrenia. The purpose of this study is to assess the level of lysosphingolipids in patients with schizophrenia, Parkinson’s disease (PD), and the control. The study includes 52 patients with schizophrenia, 170 patients with PD, and 166 neurologically healthy individuals (control group). The concentration of lysosomal substrates (hexosylsphingosine (HexSph), globotriaosylsphingosine (LysoGb3), lysosphingomyelin (LysoSM)) are measured by high-liquid chromatography with tandem mass spectrometry (HPLC-MS/MS) in blood. An increase in the concentration of LysoSM, LysoGb3, and HexSph is detected in patients with schizophrenia compared to the control (
p
< 0.0001,
p
< 0.0001,
p
< 0.0001, respectively). Our results confirm a violation of the lysosphingolipid composition of the blood in patients with schizophrenia.</description><subject>Animal Genetics and Genomics</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>blood</subject><subject>chromatography</subject><subject>dementia</subject><subject>dopamine</subject><subject>enzyme activity</subject><subject>Human Genetics</subject><subject>lysosomes</subject><subject>Microbial Genetics and Genomics</subject><subject>schizophrenia</subject><subject>sphingolipids</subject><subject>tandem mass spectrometry</subject><issn>1022-7954</issn><issn>1608-3369</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kM1OwzAQhC0EEqXwANxy5BLwT-LYR6gKRYoEUnvgFjnOunGV2sFOi8rTk6rckDjtruablWYQuiX4nhCWPSwJprSQeUYZ5hiLjzM0IRyLlDEuz8d9lNOjfomuYtxgTDDmbIIW8w72aoAmKWEPXeJN8tR5P56H6GPfWrf2ne1tExPrknc1WHBDTL7s0CZL3dpv37cBnFXX6MKoLsLN75yi1fN8NVuk5dvL6-yxTDWjZEh1UZiG11IrrTMuKEglaS1qkfFGMlFkkhnKjSCFzAgAFY1pcqqwKRoDNWVTdHd62wf_uYM4VFsbNXSdcuB3sWIkZ3mRU5mPKDmhOvgYA5iqD3arwqEiuDqWVv0pbfTQkyeOrFtDqDZ-F9wY6B_TD0h0bv8</recordid><startdate>20230601</startdate><enddate>20230601</enddate><creator>Kopytova, A. E.</creator><creator>Usenko, T. S.</creator><creator>Bezrukova, A. I.</creator><creator>Basharova, K. S.</creator><creator>Andreeva, T. V.</creator><creator>Volkova, E. V.</creator><creator>Manakhov, A. D.</creator><creator>Baydakova, G. V.</creator><creator>Palchikova, E. I.</creator><creator>Zakharova, E. Yu</creator><creator>Zalutskaya, N. M.</creator><creator>Neznanov, N. G.</creator><creator>Pchelina, S. N.</creator><general>Pleiades Publishing</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7S9</scope><scope>L.6</scope></search><sort><creationdate>20230601</creationdate><title>Elevated Level of Blood Lysosphingolipids in Patients with Schizophrenia</title><author>Kopytova, A. E. ; Usenko, T. S. ; Bezrukova, A. I. ; Basharova, K. S. ; Andreeva, T. V. ; Volkova, E. V. ; Manakhov, A. D. ; Baydakova, G. V. ; Palchikova, E. I. ; Zakharova, E. Yu ; Zalutskaya, N. M. ; Neznanov, N. G. ; Pchelina, S. N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c321t-c77fd6b9cacc4682e9a92b8b846d9387493f26f817941ee28dfd52a0f7dfeb23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animal Genetics and Genomics</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>blood</topic><topic>chromatography</topic><topic>dementia</topic><topic>dopamine</topic><topic>enzyme activity</topic><topic>Human Genetics</topic><topic>lysosomes</topic><topic>Microbial Genetics and Genomics</topic><topic>schizophrenia</topic><topic>sphingolipids</topic><topic>tandem mass spectrometry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kopytova, A. E.</creatorcontrib><creatorcontrib>Usenko, T. S.</creatorcontrib><creatorcontrib>Bezrukova, A. I.</creatorcontrib><creatorcontrib>Basharova, K. S.</creatorcontrib><creatorcontrib>Andreeva, T. V.</creatorcontrib><creatorcontrib>Volkova, E. V.</creatorcontrib><creatorcontrib>Manakhov, A. D.</creatorcontrib><creatorcontrib>Baydakova, G. V.</creatorcontrib><creatorcontrib>Palchikova, E. I.</creatorcontrib><creatorcontrib>Zakharova, E. Yu</creatorcontrib><creatorcontrib>Zalutskaya, N. M.</creatorcontrib><creatorcontrib>Neznanov, N. G.</creatorcontrib><creatorcontrib>Pchelina, S. N.</creatorcontrib><collection>CrossRef</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Russian journal of genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kopytova, A. E.</au><au>Usenko, T. S.</au><au>Bezrukova, A. I.</au><au>Basharova, K. S.</au><au>Andreeva, T. V.</au><au>Volkova, E. V.</au><au>Manakhov, A. D.</au><au>Baydakova, G. V.</au><au>Palchikova, E. I.</au><au>Zakharova, E. Yu</au><au>Zalutskaya, N. M.</au><au>Neznanov, N. G.</au><au>Pchelina, S. N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Elevated Level of Blood Lysosphingolipids in Patients with Schizophrenia</atitle><jtitle>Russian journal of genetics</jtitle><stitle>Russ J Genet</stitle><date>2023-06-01</date><risdate>2023</risdate><volume>59</volume><issue>6</issue><spage>579</spage><epage>584</epage><pages>579-584</pages><issn>1022-7954</issn><eissn>1608-3369</eissn><abstract>Schizophrenia is a mental disorder with a prevalence of 0.7–1% of the general population and is characterized by impaired dopamine transmission in neurons. Recent data have shown that lysosomal storage disorders (LSD), characterized by a decrease in enzyme activity and a corresponding accumulation of substrate in lysosomes due to mutations in lysosomal genes, can manifest a wide range of clinical symptoms including psychosis, affective disorders, early onset dementia, and schizophrenia. The purpose of this study is to assess the level of lysosphingolipids in patients with schizophrenia, Parkinson’s disease (PD), and the control. The study includes 52 patients with schizophrenia, 170 patients with PD, and 166 neurologically healthy individuals (control group). The concentration of lysosomal substrates (hexosylsphingosine (HexSph), globotriaosylsphingosine (LysoGb3), lysosphingomyelin (LysoSM)) are measured by high-liquid chromatography with tandem mass spectrometry (HPLC-MS/MS) in blood. An increase in the concentration of LysoSM, LysoGb3, and HexSph is detected in patients with schizophrenia compared to the control (
p
< 0.0001,
p
< 0.0001,
p
< 0.0001, respectively). Our results confirm a violation of the lysosphingolipid composition of the blood in patients with schizophrenia.</abstract><cop>Moscow</cop><pub>Pleiades Publishing</pub><doi>10.1134/S102279542306008X</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1022-7954 |
| ispartof | Russian journal of genetics, 2023-06, Vol.59 (6), p.579-584 |
| issn | 1022-7954 1608-3369 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3153575295 |
| source | SpringerLink Journals |
| subjects | Animal Genetics and Genomics Biomedical and Life Sciences Biomedicine blood chromatography dementia dopamine enzyme activity Human Genetics lysosomes Microbial Genetics and Genomics schizophrenia sphingolipids tandem mass spectrometry |
| title | Elevated Level of Blood Lysosphingolipids in Patients with Schizophrenia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T07%3A12%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Elevated%20Level%20of%20Blood%20Lysosphingolipids%20in%20Patients%20with%20Schizophrenia&rft.jtitle=Russian%20journal%20of%20genetics&rft.au=Kopytova,%20A.%20E.&rft.date=2023-06-01&rft.volume=59&rft.issue=6&rft.spage=579&rft.epage=584&rft.pages=579-584&rft.issn=1022-7954&rft.eissn=1608-3369&rft_id=info:doi/10.1134/S102279542306008X&rft_dat=%3Cproquest_cross%3E3153575295%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3153575295&rft_id=info:pmid/&rfr_iscdi=true |